Overview

This trial is active, not recruiting.

Condition hiv
Treatments computer-based hiv, std & hepatitis education, educator-delivered hiv, std and hepatitis education
Sponsor National Development and Research Institutes, Inc.
Collaborator Daytop (adolescent treament program)
Start date August 2004
Trial size 56 participants
Trial identifier NCT00182585, R01 DA015964

Summary

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment

Primary Outcomes

Measure
HIV risk behavior
time frame:

Secondary Outcomes

Measure
knowledge related to HIV, Hepatitis, STDs
time frame:
behavioral intentions
time frame:
attitudes toward risk-reduction behavior
time frame:
feedback on intervention
time frame:

Eligibility Criteria

Male or female participants from 13 years up to 18 years old.

Inclusion Criteria: - Aadolescents in outpatients substance abuse treatment - Ages 13 - 18 years - Within first month of treatment entry Exclusion Criteria:

Additional Information

Official title Computer-Assisted HIV Prevention for Young Drug Users
Principal investigator Lisa Marsch, PhD
Description Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.
Trial information was received from ClinicalTrials.gov and was last updated in August 2008.
Information provided to ClinicalTrials.gov by National Development and Research Institutes, Inc..